Recent Company News

• 04:10 PM ET May 18, 2026
  

  Neurocrine Biosciences presents real-world data on INGREZZA Capsules in Mild Tardive Dyskinesia ($157.21, 0.00)

• 01:00 AM ET May 13, 2026
  

  Transcript Intelligence: Mitsubishi Chemical Q4 Earnings Guidance

• 01:00 AM ET May 13, 2026
  

  Transcript Intelligence: Mitsubishi Chemical Q4 Earnings Themes

• 01:00 AM ET May 13, 2026
  

  Transcript Intelligence: Mitsubishi Chemical Q4 Earnings Q&A

• 12:40 AM ET May 13, 2026
  

  Mitsubishi Chemical reports FY net income attributable ¥11.83B vs guidance ¥47.00B and FactSet ¥45.89B [7 est, ¥34.72-51.50B] (¥1022.0000, +93.7)

• 07:41 PM ET May 12, 2026
  

  Japan Middle East earnings impacts expected to be moderate so far:

• 06:46 PM ET May 12, 2026
  

  Eli Lilly reports Surmount-maintain and Attain-maintain late-phase trials results, people with obesity maintained weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy ($989.87, 0.00)

• 11:57 PM ET May 11, 2026
  

  Asahi Kasei, Mitsui Chemicals, Mitsubishi Chemical confirm equity ratio for ethylene production facilities in Western Japan (¥1606.5000, +74)

• 07:33 PM ET Apr 22, 2026
  

  Mitsubishi Chemical revises investment plan in UK for SoarnoL; expects to record impairment loss of ~¥30B (¥941.4000, 0)

• 10:45 PM ET Apr 21, 2026
  

  StreetAccount Sector Preview - Japan Chemicals Jan-Mar Earnings